First-line PARP inhibitor maintenance after platinum chemotherapy reduces progression risk in certain patients with ovarian ...
Scientists at The Wistar Institute have solved a longstanding puzzle in ovarian cancer treatment: why anti-estrogen therapy often fails even when tumors express the hormone receptor that should make ...
Mirvetuximab soravtansine (MIRV; Elahere; AbbVie) demonstrated significant efficacy and an acceptable safety profile in the treatment of recurrent ovarian cancer, showing particular promise in ...
A panelist discusses how National Comprehensive Cancer Network (NCCN) guidelines have influenced molecular testing in ovarian cancer, highlighting the importance of biomarkers like BRCA genes for ...
2don MSN
One woman tells her story about how incredibly thankful she is after surviving ovarian cancer
Navigating the treatment of a deadly form of cancer can be not just physically, but emotionally exhausting. Finding out the ...
Ovarian cancer remains one of the most aggressive gynecological malignancies. Traditional, platinum-based chemotherapy is the standard frontline treatment providing initial benefit for the majority of ...
News Medical on MSN
Blood test offers hope for more effective ovarian cancer treatment: Study
More than 300,000 women are diagnosed with ovarian cancer globally each year. The four-year clinical trial across 15 Australian hospitals – known as SOLACE2 – was co-led by the University ...
The challenges of ovarian cancer embody the challenges that we face in women’s health. As we await the National Cancer ...
Australian Associated Press on MSN
‘Ovarian cancer is one of those diseases where you can feel totally normal until you drop dead’
"I allow myself five to 10 minutes a day to be grumpy and cry about things ... there's no use getting overly upset about it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback